Russia plans to produce 30 million doses of the experimental corona vaccine domestically this year, with a capacity to manufacture one million 70 million overseas. Russia has recently announced that it has successfully completed human trials towards the Coronavirus vaccine. That is why Russia has gone ahead in this race compared to other countries.
Claim to give vaccine first
Russian scientists claim that the world’s first coronavirus vaccine will be launched in August. Alexander Gintesburg, director of the Gameleigh National Research Center for Epidemiology and Microbiology, said that the Corona vaccine will start being given to people from 12 to 14 August. According to the Moscow Times, he said that it is likely to start production on a large scale from September by private companies
Russia claims that Moscow State Medical University has successfully completed the clinical trial for the world’s first coronavirus vaccine. Vadim Tarasov, director of the Institute for Translation Medicine and Biotechnology, said the first batch of volunteers will be discharged on July 15 and the second batch on July 20. Clinical trials began at Gammelei National Research Center for Epidemiology and Microbiology from June 18
The first human trial of the vaccine lasted one month on 38 people. The trial ended this week. The researchers concluded that it is safe to use and induces the body’s immune response (immunity response), although the strength of that response is not yet clear. A large Phase III trial involving several thousand people is expected to begin in August.
Kirill Dimitrik, head of the Russian Direct Investment Fund (RDIF), said that we believe that based on the current results, it will be approved in Russia in August and some other countries in September. It is probably the first vaccine in the world. More than 150 potential vaccines are being developed and tested to prevent the worldwide Koreana epidemic.
According to World Health Organization data, at least two final stages are being developed in third human trials, one in China and the other in Britain. Phase III trials of vaccine have been completed in Russia and two Middle East countries.
About Post Author
